| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of muscle | 6.54e-05 | 43 | 101 | 4 | GO:0008307 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYOM1 CAPN3 NACA GATA4 ARID1A MYPN ALPK3 MYMK GREM1 PLEC CDON | 3.09e-06 | 391 | 100 | 11 | GO:0051146 |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 4.78e-04 | 7 | 101 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | supramolecular fiber | CALD1 MYOM1 MAP4 MYO9B INPP5D KIF1B CAPN3 NCKAP5L MYL6B MYPN NAV3 KIF28P PLEC TXNDC2 MARCKS | 5.26e-04 | 1179 | 101 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CALD1 MYOM1 MAP4 MYO9B INPP5D KIF1B CAPN3 NCKAP5L MYL6B MYPN NAV3 KIF28P PLEC TXNDC2 MARCKS | 5.64e-04 | 1187 | 101 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 6.35e-04 | 8 | 101 | 2 | GO:0070775 | |
| Domain | PHD | 1.10e-04 | 89 | 99 | 5 | SM00249 | |
| Domain | Znf_PHD | 1.23e-04 | 91 | 99 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.50e-04 | 95 | 99 | 5 | PS50016 | |
| Domain | PWWP | 1.54e-04 | 20 | 99 | 3 | SM00293 | |
| Domain | ZF_PHD_1 | 1.58e-04 | 96 | 99 | 5 | PS01359 | |
| Domain | EPHD | 2.07e-04 | 22 | 99 | 3 | PS51805 | |
| Domain | PWWP | 2.37e-04 | 23 | 99 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.37e-04 | 23 | 99 | 3 | IPR000313 | |
| Domain | PWWP | 2.70e-04 | 24 | 99 | 3 | PS50812 | |
| Domain | Zinc_finger_PHD-type_CS | 3.92e-04 | 65 | 99 | 4 | IPR019786 | |
| Domain | CH | 3.92e-04 | 65 | 99 | 4 | SM00033 | |
| Domain | CH | 5.21e-04 | 70 | 99 | 4 | PF00307 | |
| Domain | - | 5.50e-04 | 71 | 99 | 4 | 1.10.418.10 | |
| Domain | DUF3585 | 5.74e-04 | 7 | 99 | 2 | IPR022735 | |
| Domain | DUF3585 | 5.74e-04 | 7 | 99 | 2 | PF12130 | |
| Domain | CH | 6.11e-04 | 73 | 99 | 4 | PS50021 | |
| Domain | CH-domain | 6.77e-04 | 75 | 99 | 4 | IPR001715 | |
| Domain | EPL1 | 7.63e-04 | 8 | 99 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 7.63e-04 | 8 | 99 | 2 | IPR019542 | |
| Domain | Znf_C2H2_matrin | 1.77e-03 | 12 | 99 | 2 | IPR000690 | |
| Domain | ZF_MATRIN | 4.03e-03 | 18 | 99 | 2 | PS50171 | |
| Domain | Znf_C2H2_jaz | 6.00e-03 | 22 | 99 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 6.00e-03 | 22 | 99 | 2 | PF12171 | |
| Domain | G_patch | 6.54e-03 | 23 | 99 | 2 | SM00443 | |
| Domain | G_patch_dom | 6.54e-03 | 23 | 99 | 2 | IPR000467 | |
| Domain | G_PATCH | 6.54e-03 | 23 | 99 | 2 | PS50174 | |
| Domain | G-patch | 6.54e-03 | 23 | 99 | 2 | PF01585 | |
| Domain | Znf_FYVE_PHD | 7.78e-03 | 147 | 99 | 4 | IPR011011 | |
| Domain | Bromodomain_CS | 8.32e-03 | 26 | 99 | 2 | IPR018359 | |
| Domain | Znf_PHD-finger | 8.54e-03 | 79 | 99 | 3 | IPR019787 | |
| Domain | LisH | 9.61e-03 | 28 | 99 | 2 | SM00667 | |
| Domain | LisH | 9.61e-03 | 28 | 99 | 2 | IPR006594 | |
| Domain | LISH | 9.61e-03 | 28 | 99 | 2 | PS50896 | |
| Domain | FHA | 9.61e-03 | 28 | 99 | 2 | SM00240 | |
| Domain | ZnF_U1 | 1.03e-02 | 29 | 99 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.03e-02 | 29 | 99 | 2 | IPR003604 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B CALD1 MAP4 RSL1D1 KTN1 NOC3L GPATCH4 MSL1 ZNF318 XRCC1 ARID1A LUZP1 NDUFV3 RBM25 TIAL1 MKI67 ZNF638 SPEN DDX24 PRRC2A FKBP3 TP53 RAI1 | 7.75e-15 | 954 | 104 | 23 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B TCOF1 MAP4 RSL1D1 KIF1B ZNF217 ZNF318 GPATCH8 MICALL1 RBM25 BRPF1 ZFP91 MKI67 ZNF638 CDT1 PLEC SPEN DDX24 PRG4 PRRC2A | 1.54e-13 | 774 | 104 | 20 | 15302935 |
| Pubmed | RBBP5 RSL1D1 NACA NOC3L GATA4 CC2D1A GPATCH4 MSL1 ZNF217 ZNF318 XRCC1 GPATCH8 ARID1A RBM25 RESF1 ZNF608 MYL6B ZFP91 MKI67 ZNF638 TAF5 SPEN DDX24 PRRC2A TP53 | 5.86e-13 | 1429 | 104 | 25 | 35140242 | |
| Pubmed | PDS5B ZSWIM8 TCOF1 MAP4 RSL1D1 NOC3L ZNF318 ARID1A RBM25 NUP155 MKI67 ZNF638 PLEC SPEN DDX24 PRRC2A TP53 RAI1 | 9.88e-13 | 653 | 104 | 18 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CALD1 MAP4 RSL1D1 KTN1 CC2D1A GPATCH4 LUZP1 MICALL1 ARHGAP1 SPATS2L BRPF1 ZFP91 MKI67 PLEC SPEN DDX24 PRRC2A FKBP3 | 5.48e-12 | 724 | 104 | 18 | 36232890 |
| Pubmed | ZSWIM8 BRPF3 TCOF1 GATA4 GPATCH4 ZNF318 ARID1A NCKAP5L LUZP1 C2CD2L RBM25 RESF1 ZNF608 BRPF1 ZFP91 TAF5 RAPGEF2 DDX24 TP53 RAI1 | 1.13e-10 | 1116 | 104 | 20 | 31753913 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B CALD1 TCOF1 MAP4 MYO9B RSL1D1 NACA ZNF318 XRCC1 F5 RBM25 NUP155 TIAL1 MYL6B MKI67 ZNF638 PLEC SPEN TP53 | 1.96e-10 | 1024 | 104 | 19 | 24711643 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | PDS5B RBBP5 NOC3L XRCC1 ARID1A ZFP91 SHPRH ZNF638 TAF5 DDX24 PRRC2A TP53 RAI1 | 2.01e-10 | 394 | 104 | 13 | 27248496 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B ZNF280D RBBP5 GATA4 GPATCH4 MSL1 XRCC1 GPATCH8 BRPF1 ZFP91 MKI67 SHPRH SPEN DDX24 RAI1 | 4.18e-10 | 608 | 104 | 15 | 36089195 |
| Pubmed | MAP4 RBBP5 KTN1 NACA NOC3L GPATCH4 MSL1 ZNF217 ZNF318 XRCC1 GPATCH8 LUZP1 C2CD2L SPATS2L TIAL1 MICALL2 ZFP91 TAF5 SPEN PRRC2A FKBP3 MARCKS | 4.95e-10 | 1497 | 104 | 22 | 31527615 | |
| Pubmed | TCOF1 MAP4 RSL1D1 KTN1 NACA GATA4 CC2D1A GPATCH4 MSL1 LUZP1 RBM25 SPATS2L TIAL1 MYL6B ZFP91 MKI67 PLEC PRRC2A FKBP3 MARCKS TP53 | 6.25e-10 | 1371 | 104 | 21 | 36244648 | |
| Pubmed | PDS5B MAP4 RSL1D1 INPP5D CC2D1A ZNF217 ZNF318 XRCC1 ARID1A TNRC18 RESF1 TIAL1 ZFP91 MKI67 SPEN PRRC2A FKBP3 TP53 RAI1 | 6.74e-10 | 1103 | 104 | 19 | 34189442 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | MAP4 RBBP5 INPP5D GPATCH4 MSL1 ARID1A NUP155 TIAL1 ZNF638 PLEC PRRC2A TP53 | 1.26e-09 | 370 | 104 | 12 | 22922362 |
| Pubmed | TCOF1 RBBP5 RSL1D1 KTN1 NOC3L GPATCH4 LUZP1 RBM25 SPATS2L TIAL1 BRPF1 ZFP91 MKI67 ZNF638 DDX24 PRRC2A | 4.80e-09 | 847 | 104 | 16 | 35850772 | |
| Pubmed | TCOF1 MAP4 RSL1D1 GPATCH4 MSL1 TNRC18 ASAP2 RBM25 OXA1L MKI67 PLEC DDX24 PRRC2A TP53 | 1.03e-08 | 655 | 104 | 14 | 35819319 | |
| Pubmed | CALD1 TCOF1 MAP4 KTN1 CC2D1A ZNF318 ARID1A LUZP1 RBM25 TAF5 SPEN PRRC2A TP53 | 1.08e-08 | 549 | 104 | 13 | 38280479 | |
| Pubmed | TCOF1 RSL1D1 KIF1B NOC3L CC2D1A GPATCH4 ZNF318 ARHGAP1 NUP155 MKI67 ZNF638 RAPGEF2 SPEN MARCKS CDON | 1.14e-08 | 777 | 104 | 15 | 35844135 | |
| Pubmed | CALD1 TCOF1 KTN1 KIF1B NACA CC2D1A XRCC1 LUZP1 ZNF638 PLEC PRRC2A | 1.19e-08 | 360 | 104 | 11 | 33111431 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CALD1 TCOF1 MAP4 RSL1D1 KTN1 NACA NOC3L CC2D1A GPATCH4 ZNF318 MKI67 ZNF638 PRRC2A FKBP3 MARCKS TP53 | 1.88e-08 | 934 | 104 | 16 | 33916271 |
| Pubmed | 2.73e-08 | 103 | 104 | 7 | 32744500 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MAP4 RSL1D1 NACA NOC3L F5 LUZP1 ARHGAP1 RBM25 SPATS2L NUP155 MYL6B MKI67 ZNF638 PLEC SPEN DDX24 FKBP3 MARCKS | 3.44e-08 | 1257 | 104 | 18 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B ZNF280D TCOF1 MAP4 RBBP5 RSL1D1 RGS22 KTN1 NACA NOC3L GPATCH4 RBM25 NUP155 MKI67 SPEN DDX24 FKBP3 MARCKS TP53 | 4.21e-08 | 1425 | 104 | 19 | 30948266 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TCOF1 RBBP5 RSL1D1 KTN1 GPATCH4 MSL1 ZNF318 XRCC1 GPATCH8 ARID1A RFWD3 RBM25 MKI67 ZNF638 TAF5 SPEN DDX24 RAI1 | 5.33e-08 | 1294 | 104 | 18 | 30804502 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PDS5B MAP4 MYO9B RSL1D1 KTN1 NACA NOC3L GPATCH4 XRCC1 NUP155 MKI67 DDX24 PRRC2A FKBP3 | 6.41e-08 | 759 | 104 | 14 | 35915203 |
| Pubmed | RBBP5 MYO9B MSL1 ZNF217 ARID1A ARHGAP1 TNRC18 BRPF1 PLEC PRRC2A | 6.48e-08 | 332 | 104 | 10 | 37433992 | |
| Pubmed | PDS5B CALD1 RSL1D1 NACA XRCC1 F5 LUZP1 RBM25 NUP155 TIAL1 MKI67 PLEC TP53 | 9.27e-08 | 660 | 104 | 13 | 32780723 | |
| Pubmed | CALD1 RBBP5 NACA GATA4 NDUFV3 ARHGAP1 ASAP2 RBM25 MYL6B BRPF1 PLEC PRRC2A FKBP3 MARCKS TP53 | 9.80e-08 | 916 | 104 | 15 | 32203420 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | RBBP5 GATA4 ZNF217 ARID1A TNRC18 RESF1 ZNF608 MKI67 SPEN RAI1 | 1.09e-07 | 351 | 104 | 10 | 38297188 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CALD1 TCOF1 MAP4 RSL1D1 NACA NOC3L GPATCH4 XRCC1 LUZP1 RBM25 NUP155 MYL6B ZFP91 MKI67 PLEC | 1.54e-07 | 949 | 104 | 15 | 36574265 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 TCOF1 MYO9B KIF1B ZNF217 ZNF318 ARID1A NCKAP5L LUZP1 RESF1 SPEN TP53 | 2.05e-07 | 588 | 104 | 12 | 38580884 |
| Pubmed | CALD1 TCOF1 MAP4 KTN1 KIF1B CC2D1A MICALL1 ARHGAP1 RBM25 NUP155 PDZD8 PRRC2A MARCKS | 2.07e-07 | 708 | 104 | 13 | 39231216 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | MAP4 MYO9B RSL1D1 NACA NOC3L GPATCH4 GPATCH8 RBM25 DDX24 PRRC2A TP53 | 2.46e-07 | 486 | 104 | 11 | 30940648 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.30e-07 | 148 | 104 | 7 | 32538781 | |
| Pubmed | TCOF1 MAP4 RSL1D1 CC2D1A RBM25 MYPN MKI67 ZNF638 SPEN DDX24 PRRC2A | 3.45e-07 | 503 | 104 | 11 | 16964243 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 4.73e-07 | 315 | 104 | 9 | 26777405 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | USP53 SPATA31E1 TCOF1 INPP5D TNRC18 ASAP2 NUP155 PLEC SPEN TP53 | 6.98e-07 | 430 | 104 | 10 | 35044719 |
| Pubmed | 8.92e-07 | 340 | 104 | 9 | 24332808 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TCOF1 MAP4 RSL1D1 NOC3L GPATCH8 NDUFV3 RBM25 SPATS2L TIAL1 ZNF638 SPEN DDX24 PRRC2A | 9.02e-07 | 807 | 104 | 13 | 22681889 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.14e-07 | 341 | 104 | 9 | 32971831 | |
| Pubmed | TCOF1 MAP4 MYO9B KTN1 KIF1B GPATCH4 ZNF217 ARID1A LUZP1 TNRC18 RBM25 OXA1L ZNF608 MKI67 DDX24 PRRC2A | 9.26e-07 | 1247 | 104 | 16 | 27684187 | |
| Pubmed | TCOF1 MAP4 RSL1D1 KTN1 KIF1B NACA NOC3L RBM25 PLEC TAF5 FKBP3 MARCKS TP53 | 9.27e-07 | 809 | 104 | 13 | 32129710 | |
| Pubmed | CALD1 TAPT1 MAP4 KTN1 CC2D1A LUZP1 C2CD2L ARHGAP1 NUP155 PDZD8 MARCKS | 1.13e-06 | 568 | 104 | 11 | 37774976 | |
| Pubmed | PDS5B CALD1 RSL1D1 FAM178B KTN1 NOC3L MSL1 ZNF318 ARID1A LUZP1 TNRC18 TIAL1 ZNF608 PLEC PLIN1 SPEN RAI1 | 1.30e-06 | 1442 | 104 | 17 | 35575683 | |
| Pubmed | Dysregulation of cotranscriptional alternative splicing underlies CHARGE syndrome. | 1.44e-06 | 8 | 104 | 3 | 29311329 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 CALD1 KIF1B NOC3L CC2D1A NCKAP5L LUZP1 MICALL1 ARHGAP1 MYL6B BRPF1 PLEC TP53 | 1.66e-06 | 853 | 104 | 13 | 28718761 |
| Pubmed | TAPT1 TCOF1 RSL1D1 KTN1 NOC3L CC2D1A NCKAP5L NDUFV3 MICALL1 USP31 ARHGAP1 OXA1L NUP155 DNAJC14 PDZD8 DDX24 MARCKS | 1.97e-06 | 1487 | 104 | 17 | 33957083 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.98e-06 | 123 | 104 | 6 | 26912792 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TCOF1 RSL1D1 NOC3L GPATCH4 ARID1A RBM25 MKI67 ZNF638 SPEN DDX24 RAI1 | 2.09e-06 | 605 | 104 | 11 | 28977666 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B MAP4 MYO9B RSL1D1 KTN1 NACA NOC3L GPATCH4 ARID1A LUZP1 NUP155 PRIM2 MKI67 ZNF638 PLEC DDX24 | 2.66e-06 | 1353 | 104 | 16 | 29467282 |
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 24788519 | ||
| Pubmed | 3.10e-06 | 295 | 104 | 8 | 26209609 | ||
| Pubmed | 3.43e-06 | 210 | 104 | 7 | 16565220 | ||
| Pubmed | RSL1D1 MSL1 XRCC1 F5 LUZP1 ZNF608 ZFP91 SHPRH ZNF638 SPEN RAI1 | 3.84e-06 | 645 | 104 | 11 | 25281560 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.13e-06 | 410 | 104 | 9 | 26949251 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TCOF1 MAP4 RSL1D1 KTN1 NACA CC2D1A GPATCH4 OXA1L NUP155 PRIM2 ZNF638 PLEC DDX24 PRRC2A FKBP3 MARCKS | 4.70e-06 | 1415 | 104 | 16 | 28515276 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.73e-06 | 533 | 104 | 10 | 30554943 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ZNF280D OXR1 TCOF1 GPATCH4 ARID1A RBM25 MKI67 PDZD8 DDX24 FKBP3 TP53 | 5.51e-06 | 670 | 104 | 11 | 22990118 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 5.77e-06 | 321 | 104 | 8 | 32098917 | |
| Pubmed | ZSWIM8 OXR1 TCOF1 RSL1D1 KIF1B AIRE ARID1A ARHGAP1 DNAJC14 NAV3 PDZD8 ANKRD36 PLEC RAPGEF2 PRRC2A | 6.59e-06 | 1285 | 104 | 15 | 35914814 | |
| Pubmed | 6.90e-06 | 329 | 104 | 8 | 17474147 | ||
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 7.02e-06 | 41 | 104 | 4 | 15561718 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.05e-06 | 330 | 104 | 8 | 33301849 | |
| Pubmed | DDB1 is essential for genomic stability in developing epidermis. | 7.27e-06 | 13 | 104 | 3 | 17301228 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.28e-06 | 440 | 104 | 9 | 34244565 | |
| Pubmed | 7.41e-06 | 441 | 104 | 9 | 31239290 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 7.79e-06 | 90 | 104 | 5 | 35654790 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | CALD1 MAP4 RSL1D1 KTN1 CC2D1A LUZP1 MICALL1 ARHGAP1 PLEC MARCKS | 7.87e-06 | 565 | 104 | 10 | 25468996 |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20414055 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23846734 | ||
| Pubmed | Identification of a basal-like subtype of breast ductal carcinoma in situ. | 8.86e-06 | 2 | 104 | 2 | 17234468 | |
| Pubmed | Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis. | 8.86e-06 | 2 | 104 | 2 | 21274377 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22197541 | ||
| Pubmed | Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. | 8.86e-06 | 2 | 104 | 2 | 16261166 | |
| Pubmed | TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool. | 8.86e-06 | 2 | 104 | 2 | 30467244 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28513299 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18006764 | ||
| Pubmed | Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium. | 8.86e-06 | 2 | 104 | 2 | 24651021 | |
| Pubmed | Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium. | 8.86e-06 | 2 | 104 | 2 | 33727444 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 35597299 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32142835 | ||
| Pubmed | The expression and significance of p53 protein and Ki-67 protein in pterygium. | 8.86e-06 | 2 | 104 | 2 | 26964379 | |
| Pubmed | Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway. | 8.86e-06 | 2 | 104 | 2 | 28714518 | |
| Pubmed | Potential Prognostic Value of GATA4 Depends on the p53 Expression in Primary Glioblastoma Patients. | 8.86e-06 | 2 | 104 | 2 | 37372326 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21677540 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 30616520 | ||
| Pubmed | CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa. | 8.86e-06 | 2 | 104 | 2 | 19854077 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37787291 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25029119 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25835106 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24403473 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 21753697 | ||
| Pubmed | Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. | 8.86e-06 | 2 | 104 | 2 | 10191063 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32986365 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 38382738 | ||
| Pubmed | Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors. | 8.86e-06 | 2 | 104 | 2 | 26743291 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 36049099 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16351648 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16255765 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25308006 | ||
| Pubmed | p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer. | 8.86e-06 | 2 | 104 | 2 | 12434121 | |
| Interaction | NUP43 interactions | PDS5B ZNF280D MAP4 RBBP5 RSL1D1 NOC3L GPATCH4 MSL1 ZNF318 GPATCH8 ARID1A RESF1 ZNF608 ZFP91 MKI67 RAPGEF2 SPEN DDX24 TP53 | 2.12e-10 | 625 | 100 | 19 | int:NUP43 |
| Interaction | H3C1 interactions | PDS5B ZNF280D RBBP5 RSL1D1 NACA NOC3L AIRE GPATCH4 MSL1 XRCC1 TNRC18 SPATS2L MICALL2 BRPF1 ZFP91 MKI67 SHPRH NAV3 ZNF638 TAF5 SPEN DDX24 | 4.20e-10 | 901 | 100 | 22 | int:H3C1 |
| Interaction | SMC5 interactions | PDS5B CALD1 MAP4 RSL1D1 KTN1 NOC3L GPATCH4 MSL1 ZNF318 XRCC1 ARID1A LUZP1 NDUFV3 RBM25 TIAL1 MKI67 ZNF638 SPEN DDX24 PRRC2A FKBP3 TP53 RAI1 | 5.02e-10 | 1000 | 100 | 23 | int:SMC5 |
| Interaction | SNRNP40 interactions | ZNF280D TCOF1 RSL1D1 NOC3L GPATCH4 ZNF217 ZNF318 XRCC1 GPATCH8 ARID1A RBM25 ZNF608 PRIM2 MKI67 PDZD8 SPEN DDX24 | 1.47e-08 | 637 | 100 | 17 | int:SNRNP40 |
| Interaction | SIRT7 interactions | PDS5B ZSWIM8 TCOF1 MAP4 RSL1D1 NOC3L ZNF318 ARID1A RBM25 NUP155 MKI67 ZNF638 PLEC SPEN DDX24 PRRC2A TP53 RAI1 | 2.37e-08 | 744 | 100 | 18 | int:SIRT7 |
| Interaction | MEN1 interactions | PDS5B TCOF1 RBBP5 RSL1D1 KTN1 NOC3L GPATCH4 XRCC1 ARID1A LUZP1 RBM25 TIAL1 ZNF608 BRPF1 ZFP91 MKI67 ZNF638 SPEN DDX24 PRRC2A TP53 | 2.63e-08 | 1029 | 100 | 21 | int:MEN1 |
| Interaction | H2BC21 interactions | PDS5B BRPF3 ZNF280D RBBP5 AIRE MSL1 XRCC1 ARID1A C2CD2L BRPF1 MKI67 SHPRH ZNF638 PRRC2A TP53 RAI1 | 3.12e-07 | 696 | 100 | 16 | int:H2BC21 |
| Interaction | ZNF330 interactions | PDS5B RSL1D1 NOC3L GPATCH4 MSL1 XRCC1 GPATCH8 BRPF1 ZFP91 SHPRH DDX24 RAI1 CCDC33 | 3.18e-07 | 446 | 100 | 13 | int:ZNF330 |
| Interaction | FBL interactions | USP53 BRPF3 TCOF1 RSL1D1 KTN1 NOC3L GPATCH4 ZNF318 SPATS2L ZFP91 MKI67 DDX24 PRRC2A FKBP3 TP53 | 5.85e-07 | 639 | 100 | 15 | int:FBL |
| Interaction | H3C3 interactions | PDS5B ZNF280D RBBP5 GATA4 GPATCH4 MSL1 BRPF1 ZFP91 MKI67 SHPRH SPEN DDX24 RAI1 | 1.03e-06 | 495 | 100 | 13 | int:H3C3 |
| Interaction | KCNA3 interactions | CALD1 TCOF1 MAP4 KTN1 KIF1B NACA CC2D1A LUZP1 MICALL1 ARHGAP1 ASAP2 RBM25 NUP155 PDZD8 SPEN PRRC2A MARCKS | 1.25e-06 | 871 | 100 | 17 | int:KCNA3 |
| Interaction | H2AC4 interactions | PDS5B RBBP5 NOC3L XRCC1 ARID1A MICALL2 ZFP91 SHPRH ZNF638 DDX24 PRRC2A TP53 RAI1 | 1.31e-06 | 506 | 100 | 13 | int:H2AC4 |
| Interaction | FOXP3 interactions | MAP4 RBBP5 INPP5D GPATCH4 MSL1 ARID1A NUP155 TIAL1 ZNF638 PLEC PRRC2A TP53 | 1.55e-06 | 432 | 100 | 12 | int:FOXP3 |
| Interaction | CIT interactions | PDS5B TAPT1 TCOF1 RBBP5 MYO9B RSL1D1 KTN1 NACA NOC3L GPATCH4 XRCC1 LUZP1 RBM25 NUP155 TIAL1 MYL6B MKI67 ZNF638 PLEC TAF5 PRRC2A TP53 | 1.93e-06 | 1450 | 100 | 22 | int:CIT |
| Interaction | MEX3A interactions | RBBP5 MYO9B MSL1 ZNF217 ARID1A ARHGAP1 TNRC18 BRPF1 PLEC PRRC2A TP53 | 3.24e-06 | 384 | 100 | 11 | int:MEX3A |
| Interaction | PRR11 interactions | 3.84e-06 | 130 | 100 | 7 | int:PRR11 | |
| Interaction | CUL7 interactions | BRPF3 CALD1 TCOF1 RSL1D1 XRCC1 RBM25 OXA1L NUP155 TIAL1 MKI67 MROH7 ZNF638 PLEC SPEN PRRC2A TP53 | 3.94e-06 | 845 | 100 | 16 | int:CUL7 |
| Interaction | CSNK2A1 interactions | CALD1 TCOF1 RBBP5 RSL1D1 KIF1B NACA GATA4 ZNF217 XRCC1 ANKRD36C F5 SPATS2L ANKRD36 DDX24 FKBP3 MARCKS TP53 | 4.38e-06 | 956 | 100 | 17 | int:CSNK2A1 |
| Interaction | BRD3 interactions | PDS5B MYO9B CC2D1A XRCC1 ARID1A RBM25 MYL6B ZFP91 MKI67 TAF5 TP53 RAI1 | 6.12e-06 | 494 | 100 | 12 | int:BRD3 |
| Interaction | HECTD1 interactions | PDS5B MAP4 MYO9B RSL1D1 KTN1 NACA NOC3L GPATCH4 XRCC1 RBM25 NUP155 MKI67 CDT1 DDX24 PRRC2A FKBP3 TP53 | 6.43e-06 | 984 | 100 | 17 | int:HECTD1 |
| Interaction | NUPR1 interactions | PDS5B CALD1 RSL1D1 NACA MSL1 XRCC1 F5 LUZP1 RBM25 NUP155 TIAL1 MKI67 PLEC TP53 | 6.91e-06 | 683 | 100 | 14 | int:NUPR1 |
| Interaction | SSRP1 interactions | RBBP5 RSL1D1 AIRE XRCC1 ARID1A BRPF1 PRIM2 ZFP91 ZNF638 TXNDC2 PRRC2A MARCKS TP53 RAI1 | 7.14e-06 | 685 | 100 | 14 | int:SSRP1 |
| Interaction | ACE2 interactions | USP53 CALD1 TCOF1 MAP4 RSL1D1 KTN1 CC2D1A ZNF217 XRCC1 MICALL1 ARHGAP1 RBM25 NUP155 MKI67 PLEC FKBP3 MARCKS TP53 | 7.54e-06 | 1106 | 100 | 18 | int:ACE2 |
| Interaction | TOP1 interactions | TCOF1 RBBP5 GATA4 XRCC1 ARID1A RBM25 BRPF1 PRIM2 MKI67 ZNF638 CDT1 DDX24 TP53 RAI1 | 8.56e-06 | 696 | 100 | 14 | int:TOP1 |
| Interaction | NEIL3 interactions | 8.80e-06 | 97 | 100 | 6 | int:NEIL3 | |
| Interaction | CEBPA interactions | PDS5B MAP4 RSL1D1 INPP5D CC2D1A ZNF217 ZNF318 XRCC1 ARID1A TNRC18 RESF1 TIAL1 ZFP91 MKI67 SPEN PRRC2A FKBP3 TP53 RAI1 | 1.02e-05 | 1245 | 100 | 19 | int:CEBPA |
| Interaction | MYCN interactions | PDS5B BRPF3 TCOF1 RSL1D1 KTN1 NACA NOC3L GPATCH4 GPATCH8 ARID1A SPATS2L NUP155 TIAL1 MYL6B MKI67 ZNF638 DDX24 PRRC2A MARCKS RAI1 | 1.13e-05 | 1373 | 100 | 20 | int:MYCN |
| Interaction | CSNK2A2 interactions | BRPF3 TCOF1 RBBP5 KIF1B NACA GATA4 XRCC1 ANKRD36C BRPF1 MKI67 ANKRD36 DDX24 FKBP3 TP53 | 1.21e-05 | 718 | 100 | 14 | int:CSNK2A2 |
| Interaction | KIF20A interactions | PDS5B BRPF3 RSL1D1 KTN1 NOC3L ZNF318 LUZP1 RBM25 NUP155 MYL6B MKI67 NAV3 ZNF638 PDZD8 PLEC PRRC2A TP53 | 1.54e-05 | 1052 | 100 | 17 | int:KIF20A |
| Interaction | BRD7 interactions | MAP4 MYO9B RSL1D1 NACA NOC3L GPATCH4 GPATCH8 ARID1A RBM25 MKI67 DDX24 PRRC2A TP53 | 1.59e-05 | 637 | 100 | 13 | int:BRD7 |
| Interaction | CENPA interactions | PDS5B NOC3L GPATCH4 BRPF1 ZFP91 TBC1D14 SHPRH DDX24 TP53 RAI1 | 1.81e-05 | 377 | 100 | 10 | int:CENPA |
| Interaction | SOX2 interactions | RBBP5 MYO9B RSL1D1 NOC3L GATA4 MSL1 ZNF217 XRCC1 ARID1A LUZP1 ARHGAP1 TNRC18 SPATS2L TIAL1 ZNF608 MYL6B NAV3 ZNF638 SPEN DDX24 | 1.89e-05 | 1422 | 100 | 20 | int:SOX2 |
| Interaction | GNL2 interactions | USP53 BRPF3 RBBP5 RSL1D1 NOC3L GPATCH4 SPATS2L MKI67 PRRC2A TP53 | 2.21e-05 | 386 | 100 | 10 | int:GNL2 |
| Interaction | FBXO32 interactions | 2.21e-05 | 386 | 100 | 10 | int:FBXO32 | |
| Interaction | NAA40 interactions | CALD1 TCOF1 MAP4 RSL1D1 KTN1 NACA NOC3L CC2D1A GPATCH4 ZNF318 MKI67 ZNF638 PRRC2A FKBP3 MARCKS TP53 | 2.43e-05 | 978 | 100 | 16 | int:NAA40 |
| Interaction | EFTUD2 interactions | TCOF1 MAP4 RBBP5 RSL1D1 KTN1 NACA AIRE CC2D1A GPATCH4 ZNF217 NUP155 PRIM2 ZNF638 PDZD8 PLEC DDX24 PRRC2A FKBP3 MARCKS TP53 | 2.48e-05 | 1449 | 100 | 20 | int:EFTUD2 |
| Interaction | DNAH3 interactions | 2.52e-05 | 12 | 100 | 3 | int:DNAH3 | |
| Interaction | EYA4 interactions | 2.85e-05 | 243 | 100 | 8 | int:EYA4 | |
| Interaction | HDAC1 interactions | RBBP5 GATA4 AIRE ZNF217 ZNF318 ARID1A LUZP1 TNRC18 RBM25 ZNF608 MKI67 ZNF638 PLEC SPEN FKBP3 TP53 RAI1 | 2.98e-05 | 1108 | 100 | 17 | int:HDAC1 |
| Interaction | RPL31 interactions | PDS5B TCOF1 RSL1D1 NACA NOC3L CC2D1A GPATCH4 SPATS2L ZFP91 MKI67 PDZD8 DDX24 TP53 | 3.14e-05 | 680 | 100 | 13 | int:RPL31 |
| Interaction | DHX40 interactions | 3.39e-05 | 249 | 100 | 8 | int:DHX40 | |
| Interaction | RNF113A interactions | TCOF1 MAP4 RSL1D1 GPATCH4 MSL1 TNRC18 ASAP2 RBM25 OXA1L MKI67 PLEC DDX24 PRRC2A | 3.76e-05 | 692 | 100 | 13 | int:RNF113A |
| Interaction | CRX interactions | 3.91e-05 | 254 | 100 | 8 | int:CRX | |
| Interaction | MNDA interactions | 4.24e-05 | 188 | 100 | 7 | int:MNDA | |
| Interaction | DOT1L interactions | TCOF1 RSL1D1 KTN1 NOC3L GPATCH4 LUZP1 RBM25 SPATS2L BRPF1 MKI67 ZNF638 DDX24 PRRC2A TP53 | 4.40e-05 | 807 | 100 | 14 | int:DOT1L |
| Interaction | NUP50 interactions | 5.04e-05 | 341 | 100 | 9 | int:NUP50 | |
| Interaction | SRPK2 interactions | TCOF1 MAP4 RSL1D1 NOC3L GPATCH4 GPATCH8 F5 ZFP91 MKI67 ZNF638 SPEN DDX24 PRRC2A | 5.40e-05 | 717 | 100 | 13 | int:SRPK2 |
| Interaction | TOP2A interactions | PDS5B RBBP5 KTN1 GATA4 AIRE ARID1A RESF1 PRIM2 PDZD8 CDT1 TP53 | 5.42e-05 | 520 | 100 | 11 | int:TOP2A |
| Interaction | ARL16 interactions | 5.81e-05 | 83 | 100 | 5 | int:ARL16 | |
| Interaction | LINC00240 interactions | 6.33e-05 | 16 | 100 | 3 | int:LINC00240 | |
| Interaction | TRIM37 interactions | MAP4 NACA ZNF217 ZNF318 NCKAP5L RBM25 MYL6B MKI67 PLEC SPEN TP53 CCDC33 | 6.70e-05 | 630 | 100 | 12 | int:TRIM37 |
| Interaction | FEV interactions | 6.88e-05 | 203 | 100 | 7 | int:FEV | |
| Interaction | CCDC54 interactions | 7.29e-05 | 3 | 100 | 2 | int:CCDC54 | |
| Interaction | SOX15 interactions | 7.33e-05 | 141 | 100 | 6 | int:SOX15 | |
| Interaction | ZBTB2 interactions | BRPF3 TAPT1 RSL1D1 NOC3L GPATCH4 ZFP91 DDX24 FKBP3 MARCKS TP53 | 8.04e-05 | 450 | 100 | 10 | int:ZBTB2 |
| Interaction | H3-3A interactions | PDS5B ZNF280D RBBP5 GATA4 MSL1 XRCC1 GPATCH8 BRPF1 ZFP91 MKI67 SHPRH SPEN RAI1 | 8.41e-05 | 749 | 100 | 13 | int:H3-3A |
| Interaction | ARL4D interactions | 8.88e-05 | 146 | 100 | 6 | int:ARL4D | |
| Interaction | TERF2IP interactions | PDS5B GPATCH4 ZNF318 XRCC1 ARID1A ZNF608 MKI67 ZNF638 SPEN DDX24 RAI1 | 9.23e-05 | 552 | 100 | 11 | int:TERF2IP |
| Interaction | YAP1 interactions | CALD1 TCOF1 MAP4 CC2D1A ZNF318 ARID1A LUZP1 TNRC18 RBM25 MYL6B PLEC TAF5 RAPGEF2 SPEN PRRC2A TP53 | 9.35e-05 | 1095 | 100 | 16 | int:YAP1 |
| Interaction | CCDC8 interactions | MAP4 MYO9B NACA AFF3 ZNF318 F5 NUP155 MYL6B MKI67 PLEC MARCKS TP53 | 9.83e-05 | 656 | 100 | 12 | int:CCDC8 |
| Interaction | NEUROG3 interactions | 9.94e-05 | 149 | 100 | 6 | int:NEUROG3 | |
| Interaction | H1-5 interactions | MAP4 MYO9B RSL1D1 GATA4 MSL1 ASAP2 MICALL2 PDZD8 RAPGEF2 DDX24 | 1.02e-04 | 463 | 100 | 10 | int:H1-5 |
| Interaction | RPL4 interactions | RSL1D1 KTN1 NOC3L GPATCH4 SPATS2L MICALL2 MKI67 ZNF638 PDZD8 SPEN DDX24 PRRC2A TP53 | 1.03e-04 | 764 | 100 | 13 | int:RPL4 |
| Interaction | BMI1 interactions | RSL1D1 KTN1 GATA4 GPATCH8 SPATS2L TIAL1 MKI67 ZNF638 PLEC SPEN PRRC2A TP53 | 1.03e-04 | 659 | 100 | 12 | int:BMI1 |
| Interaction | RPS6 interactions | USP53 PDS5B RSL1D1 NOC3L GATA4 GPATCH4 XRCC1 SPATS2L MICALL2 ZFP91 MKI67 PDZD8 DDX24 TP53 | 1.03e-04 | 874 | 100 | 14 | int:RPS6 |
| Interaction | DHX8 interactions | 1.04e-04 | 292 | 100 | 8 | int:DHX8 | |
| Interaction | TTN interactions | 1.22e-04 | 299 | 100 | 8 | int:TTN | |
| Interaction | NOP56 interactions | USP53 TCOF1 RSL1D1 NOC3L GATA4 AIRE GPATCH4 MKI67 DDX24 PRRC2A TP53 | 1.22e-04 | 570 | 100 | 11 | int:NOP56 |
| Interaction | H2BC8 interactions | PDS5B ZNF280D RBBP5 GPATCH4 MSL1 XRCC1 BRPF1 ZFP91 MKI67 SPEN RAI1 | 1.34e-04 | 576 | 100 | 11 | int:H2BC8 |
| Interaction | ZNF668 interactions | 1.34e-04 | 226 | 100 | 7 | int:ZNF668 | |
| Interaction | DDX23 interactions | PDS5B TCOF1 RSL1D1 NOC3L GPATCH4 GPATCH8 RBM25 BRPF1 ZNF638 DDX24 | 1.36e-04 | 480 | 100 | 10 | int:DDX23 |
| Interaction | SP7 interactions | 1.37e-04 | 304 | 100 | 8 | int:SP7 | |
| Interaction | EMD interactions | TAPT1 KTN1 GATA4 CC2D1A ZNF217 C2CD2L ARHGAP1 NUP155 DNAJC14 PDZD8 DDX24 MARCKS CCDC33 | 1.41e-04 | 789 | 100 | 13 | int:EMD |
| Interaction | NLE1 interactions | 1.42e-04 | 228 | 100 | 7 | int:NLE1 | |
| Interaction | OBSL1 interactions | PDS5B SELENOP CALD1 TCOF1 RSL1D1 RBM25 SPATS2L NUP155 TIAL1 MKI67 ZNF638 PLEC SPEN TP53 | 1.44e-04 | 902 | 100 | 14 | int:OBSL1 |
| Interaction | CDK9 interactions | TCOF1 MAP4 AFF3 MSL1 RBM25 NUP155 MROH7 ZNF638 PLEC DDX24 FKBP3 TP53 | 1.47e-04 | 685 | 100 | 12 | int:CDK9 |
| Interaction | HULC interactions | 1.52e-04 | 161 | 100 | 6 | int:HULC | |
| Interaction | FUBP1 interactions | 1.53e-04 | 309 | 100 | 8 | int:FUBP1 | |
| Interaction | POLR1G interactions | PDS5B TCOF1 RSL1D1 NOC3L GPATCH4 XRCC1 BRPF1 ZFP91 DDX24 RAI1 | 1.59e-04 | 489 | 100 | 10 | int:POLR1G |
| Interaction | NACA interactions | 1.67e-04 | 234 | 100 | 7 | int:NACA | |
| Interaction | ISG15 interactions | CALD1 MAP4 RSL1D1 NACA ZNF318 LUZP1 RBM25 SPATS2L MYL6B PLEC | 1.72e-04 | 494 | 100 | 10 | int:ISG15 |
| Interaction | BRPF3 interactions | 1.80e-04 | 166 | 100 | 6 | int:BRPF3 | |
| Interaction | SAP30 interactions | 1.85e-04 | 167 | 100 | 6 | int:SAP30 | |
| Interaction | SMG7 interactions | 1.90e-04 | 319 | 100 | 8 | int:SMG7 | |
| Interaction | PTEN interactions | CALD1 TCOF1 RBBP5 RSL1D1 NACA ZNF318 ARID1A LUZP1 MKI67 PLEC DDX24 PRRC2A MARCKS TP53 | 1.95e-04 | 929 | 100 | 14 | int:PTEN |
| Interaction | RPL5 interactions | USP53 TCOF1 RSL1D1 KTN1 CC2D1A MICALL2 PDZD8 DDX24 PRRC2A MARCKS TP53 | 2.09e-04 | 606 | 100 | 11 | int:RPL5 |
| Interaction | SEC62 interactions | CALD1 TAPT1 MAP4 KTN1 C2CD2L ARHGAP1 NUP155 DNAJC14 PDZD8 RAPGEF2 | 2.09e-04 | 506 | 100 | 10 | int:SEC62 |
| Interaction | EGR2 interactions | 2.11e-04 | 171 | 100 | 6 | int:EGR2 | |
| Interaction | H1-1 interactions | PDS5B RBBP5 RSL1D1 NOC3L GATA4 GPATCH4 MICALL1 ASAP2 SPATS2L DDX24 | 2.12e-04 | 507 | 100 | 10 | int:H1-1 |
| Interaction | NOC3L interactions | 2.15e-04 | 244 | 100 | 7 | int:NOC3L | |
| Interaction | CHD4 interactions | TCOF1 RSL1D1 NOC3L GATA4 GPATCH8 ARID1A RBM25 MKI67 SHPRH ZNF638 SPEN DDX24 TP53 RAI1 | 2.16e-04 | 938 | 100 | 14 | int:CHD4 |
| Interaction | KAT6A interactions | BRPF3 RSL1D1 MSL1 OXA1L SPATS2L BRPF1 SHPRH TAF5 MARCKS TP53 | 2.23e-04 | 510 | 100 | 10 | int:KAT6A |
| Interaction | KLF8 interactions | 2.34e-04 | 329 | 100 | 8 | int:KLF8 | |
| Interaction | BICD1 interactions | 2.50e-04 | 250 | 100 | 7 | int:BICD1 | |
| Interaction | PHLPP1 interactions | 2.54e-04 | 333 | 100 | 8 | int:PHLPP1 | |
| Interaction | SMYD1 interactions | 2.55e-04 | 62 | 100 | 4 | int:SMYD1 | |
| Interaction | ING5 interactions | 2.60e-04 | 114 | 100 | 5 | int:ING5 | |
| Interaction | RHOB interactions | PDS5B MYO9B RSL1D1 CC2D1A NCKAP5L C2CD2L MICALL1 USP31 ARHGAP1 NUP155 MYL6B DDX24 MARCKS | 2.60e-04 | 840 | 100 | 13 | int:RHOB |
| Interaction | LRRC59 interactions | TAPT1 RSL1D1 KTN1 ZNF318 C2CD2L ARHGAP1 SPATS2L NUP155 PDZD8 DDX24 PRRC2A MARCKS TP53 | 2.76e-04 | 845 | 100 | 13 | int:LRRC59 |
| Interaction | FGFBP1 interactions | 2.95e-04 | 257 | 100 | 7 | int:FGFBP1 | |
| GeneFamily | PWWP domain containing | 6.50e-05 | 22 | 65 | 3 | 1147 | |
| GeneFamily | PHD finger proteins | 3.08e-04 | 90 | 65 | 4 | 88 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.69e-03 | 161 | 65 | 4 | 593 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.81e-03 | 22 | 65 | 2 | 579 | |
| Coexpression | HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN | 3.15e-06 | 26 | 103 | 4 | M2566 | |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP | TCOF1 MAP4 NACA XRCC1 ARHGAP1 MYL6B PRIM2 TAF5 PRRC2A FKBP3 TP53 | 3.29e-06 | 484 | 103 | 11 | M14665 |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.45e-05 | 200 | 103 | 7 | M9484 | |
| Coexpression | FISCHER_DREAM_TARGETS | USP53 PDS5B TCOF1 NOC3L GPATCH4 XRCC1 RFWD3 DDIAS NUP155 PRIM2 MKI67 CDT1 TAF5 MARCKS | 2.62e-05 | 969 | 103 | 14 | M149 |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_2HR_DN | 2.71e-05 | 89 | 103 | 5 | M8916 | |
| Coexpression | WHITFIELD_CELL_CYCLE_S | 2.88e-05 | 150 | 103 | 6 | M2075 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 4.74e-05 | 164 | 103 | 6 | M5653 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 5.79e-05 | 170 | 103 | 6 | M5657 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 9.49e-05 | 363 | 103 | 8 | M6315 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.09e-04 | 475 | 103 | 9 | M40979 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 1.12e-04 | 372 | 103 | 8 | MM1043 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 1.34e-04 | 198 | 103 | 6 | M6128 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 1.42e-04 | 200 | 103 | 6 | M8081 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 1.42e-04 | 200 | 103 | 6 | M8088 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 1.42e-04 | 200 | 103 | 6 | M8090 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 1.42e-04 | 200 | 103 | 6 | M6247 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN | 1.42e-04 | 200 | 103 | 6 | M7992 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 1.42e-04 | 200 | 103 | 6 | M5247 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 1.42e-04 | 200 | 103 | 6 | M9041 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-08 | 188 | 103 | 8 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.19e-07 | 110 | 103 | 6 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-07 | 192 | 103 | 7 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.72e-06 | 186 | 103 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.72e-06 | 186 | 103 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-06 | 189 | 103 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-06 | 190 | 103 | 6 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | distal-1-Hematologic-IGSF21+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.01e-06 | 194 | 103 | 6 | f30c866e5f41ee79bdc6b6e08af962d62b199835 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.19e-06 | 195 | 103 | 6 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.56e-06 | 197 | 103 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_naive|COVID-19_Severe / Disease, condition lineage and cell class | 7.15e-06 | 200 | 103 | 6 | 5ba9c541fa356d34f392a63274dcd7bfb844cbb6 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.15e-06 | 200 | 103 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.30e-05 | 130 | 103 | 5 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 4.46e-05 | 168 | 103 | 5 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 171 | 103 | 5 | a474aaed3ca4cacb0ab565c35f25d92a10f531b7 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.85e-05 | 171 | 103 | 5 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-05 | 171 | 103 | 5 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.26e-05 | 174 | 103 | 5 | 7f1e26b58b66f4ac4c3bc315354bd620ad782eaa | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.26e-05 | 174 | 103 | 5 | 2479e4804253f55647d2192e40566d713419c51b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.41e-05 | 175 | 103 | 5 | d544f24ee33783ed4afb4d7ec079a4484118bb15 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 176 | 103 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 5.56e-05 | 176 | 103 | 5 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 178 | 103 | 5 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 178 | 103 | 5 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 6.18e-05 | 180 | 103 | 5 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.68e-05 | 183 | 103 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.59e-05 | 188 | 103 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.59e-05 | 188 | 103 | 5 | 9acb7a95e3095f15918a5d094107d1d565a42842 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-05 | 190 | 103 | 5 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-05 | 190 | 103 | 5 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-05 | 190 | 103 | 5 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 7.98e-05 | 190 | 103 | 5 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-05 | 191 | 103 | 5 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 8.18e-05 | 191 | 103 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.18e-05 | 191 | 103 | 5 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.18e-05 | 191 | 103 | 5 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.18e-05 | 191 | 103 | 5 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-05 | 192 | 103 | 5 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.38e-05 | 192 | 103 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.38e-05 | 192 | 103 | 5 | 800edadd1d1ba6b7e0a0398030dd4b61c9c480c7 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.59e-05 | 193 | 103 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-05 | 193 | 103 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 193 | 103 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.59e-05 | 193 | 103 | 5 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | severe_influenza-B_naive|severe_influenza / disease group, cell group and cell class (v2) | 8.80e-05 | 194 | 103 | 5 | 7c1e9ce5de3bb1657a67010de673c8bb60129cb6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 8.80e-05 | 194 | 103 | 5 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.80e-05 | 194 | 103 | 5 | 82753b90ca3b563275c41b6040ebbcd99b185e24 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-05 | 194 | 103 | 5 | f0c113edb706d53792892115b67277a285219942 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 194 | 103 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.80e-05 | 194 | 103 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | COVID-19_Severe-B_naive|World / disease group, cell group and cell class | 8.80e-05 | 194 | 103 | 5 | d363963a6caeedf4f9e9ad22dcf9b66b85c79a48 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.80e-05 | 194 | 103 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.80e-05 | 194 | 103 | 5 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Control-B_naive-2|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.01e-05 | 195 | 103 | 5 | 50b1795eb37551777db13b8e9d2df1ef020bfa13 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.01e-05 | 195 | 103 | 5 | 8f5a664dd65c38afe23c6acd0a9c22ba4fd347ed | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.01e-05 | 195 | 103 | 5 | e830f0c545be87a1056a4505bdf6845e5ac7750d | |
| ToppCell | Influenza_Severe-B_naive|Influenza_Severe / Disease group and Cell class | 9.01e-05 | 195 | 103 | 5 | a25516ed670c7738670ffbaa6f7cd167946f3825 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.01e-05 | 195 | 103 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | mild_COVID-19-B_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.23e-05 | 196 | 103 | 5 | 00398079d3ac14dc2026c0cbd7388f1f3257b134 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.46e-05 | 197 | 103 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-05 | 197 | 103 | 5 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.46e-05 | 197 | 103 | 5 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.46e-05 | 197 | 103 | 5 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | COVID-19_Severe-B_naive|COVID-19_Severe / disease group, cell group and cell class | 9.46e-05 | 197 | 103 | 5 | b8f18b39435e2229ba3bc07a25eb875d1ec11f6f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 8bc07beace200ae2ad41e932b72fdcc7ff08b812 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.92e-05 | 199 | 103 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 1.02e-04 | 200 | 103 | 5 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_naive|Influenza_Severe / Disease, condition lineage and cell class | 1.02e-04 | 200 | 103 | 5 | 0e05600d725dc5cc9afccc11eedc60efa41e4e46 | |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.02e-04 | 200 | 103 | 5 | b665f36dcf3c9d3981ee96f2973512f751612542 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | Transverse-B_cell-Follicular_B_cell|B_cell / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | f48557c8552da8acf695f3e43a9152e3f51b1978 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | mild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 200 | 103 | 5 | d0467cab6a42bf780aa49046bf3231ca161dc144 | |
| ToppCell | Severe-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.57e-04 | 117 | 103 | 4 | b5c27f24272216fa9f9107f5d00f3077847bb7ed | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 118 | 103 | 4 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 118 | 103 | 4 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-4|TCGA-Uterus / Sample_Type by Project: Shred V9 | 2.43e-04 | 131 | 103 | 4 | 1801611e6b63aa07629e7ccc692f45a7e93c8dd8 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.72e-04 | 135 | 103 | 4 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | Severe-B_naive-9|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.04e-04 | 139 | 103 | 4 | b9b049953958f15d773eb5cca6d5dc34f4829543 | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.30e-04 | 142 | 103 | 4 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | Severe-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.30e-04 | 142 | 103 | 4 | 9c7d5783302974b883bd887f997d094eb5925ec2 | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.28e-06 | 176 | 102 | 8 | 958_DN | |
| Drug | deoxynivalenol | TCOF1 MAP4 RBBP5 RSL1D1 INPP5D XRCC1 RBM25 NUP155 MKI67 PLEC MARCKS TP53 | 1.67e-06 | 481 | 102 | 12 | ctd:C007262 |
| Drug | testosterone enanthate | TCOF1 RBBP5 RSL1D1 GATA4 GPATCH8 USP31 RBM25 GREM1 RAPGEF2 SPEN DDX24 MARCKS | 1.03e-05 | 575 | 102 | 12 | ctd:C004648 |
| Disease | Hypertrophic Cardiomyopathy | 4.80e-05 | 57 | 103 | 4 | C0007194 | |
| Disease | cadherin-7 measurement | 1.20e-04 | 5 | 103 | 2 | EFO_0801438 | |
| Disease | stomach cancer (is_implicated_in) | 1.20e-04 | 72 | 103 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Testicular Germ Cell Tumor | 1.27e-04 | 73 | 103 | 4 | EFO_1000566 | |
| Disease | Colorectal Carcinoma | 1.76e-04 | 702 | 103 | 10 | C0009402 | |
| Disease | torsin-1A-interacting protein 1 measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0802137 | |
| Disease | solute carrier family 22 member 16 measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0802079 | |
| Disease | heart function measurement | 2.28e-04 | 34 | 103 | 3 | EFO_0004311 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 2.51e-04 | 7 | 103 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | left ventricular ejection fraction measurement | 3.72e-04 | 40 | 103 | 3 | EFO_0008373 | |
| Disease | Colorectal Neoplasms | 4.33e-04 | 277 | 103 | 6 | C0009404 | |
| Disease | liver fat measurement | 4.61e-04 | 43 | 103 | 3 | EFO_0010821 | |
| Disease | mean reticulocyte volume | PDS5B MYO9B NEXMIF AFF3 NOC3L ZNF217 ZNF318 RESF1 ZNF638 TP53 | 4.90e-04 | 799 | 103 | 10 | EFO_0010701 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 5.27e-04 | 45 | 103 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | neuroblastoma (is_implicated_in) | 5.33e-04 | 10 | 103 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Umbilical hernia | 6.50e-04 | 11 | 103 | 2 | HP_0001537 | |
| Disease | immature platelet fraction | 6.96e-04 | 114 | 103 | 4 | EFO_0009187 | |
| Disease | optic disc size measurement | 7.77e-04 | 205 | 103 | 5 | EFO_0004832 | |
| Disease | blood nickel measurement | 8.43e-04 | 120 | 103 | 4 | EFO_0007583 | |
| Disease | mean platelet volume | PDS5B RBBP5 MYO9B KIF1B NACA AFF3 GATA4 ZNF217 TBC1D14 KIF28P PLEC | 8.77e-04 | 1020 | 103 | 11 | EFO_0004584 |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0802114 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 9.82e-04 | 216 | 103 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | Adenocarcinoma Of Esophagus | 1.07e-03 | 14 | 103 | 2 | C0279628 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 1.07e-03 | 14 | 103 | 2 | cv:C2931907 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 1.23e-03 | 15 | 103 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | platelet component distribution width | 1.32e-03 | 755 | 103 | 9 | EFO_0007984 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.40e-03 | 16 | 103 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 1.40e-03 | 16 | 103 | 2 | C0079772 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.40e-03 | 16 | 103 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.40e-03 | 16 | 103 | 2 | C2713443 | |
| Disease | Adenomatous Polyposis Coli | 1.59e-03 | 17 | 103 | 2 | C0032580 | |
| Disease | sexual dimorphism measurement | SELENOP BRPF3 MYO9B MSL1 ARID1A ZNF608 ALPK3 ZNF638 MYMK PLEC TP53 | 1.68e-03 | 1106 | 103 | 11 | EFO_0021796 |
| Disease | JT interval | 1.81e-03 | 248 | 103 | 5 | EFO_0007885 | |
| Disease | body surface area | 1.89e-03 | 643 | 103 | 8 | EFO_0022196 | |
| Disease | breast cancer (is_implicated_in) | 1.92e-03 | 150 | 103 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | Pheochromocytoma | 1.99e-03 | 19 | 103 | 2 | C0031511 | |
| Disease | pentachlorophenol measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0008360 | |
| Disease | colorectal adenoma (is_marker_for) | 2.20e-03 | 20 | 103 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | coagulation factor V measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0008087 | |
| Disease | bipolar disorder, schizophrenia, response to lithium ion | 2.20e-03 | 20 | 103 | 2 | GO_0010226, MONDO_0004985, MONDO_0005090 | |
| Disease | Paroxysmal atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.21e-03 | 156 | 103 | 4 | C2585653 | |
| Disease | DDT metabolite measurement | 2.24e-03 | 74 | 103 | 3 | EFO_0007886 | |
| Disease | stem Cell Growth Factor beta measurement | 2.32e-03 | 75 | 103 | 3 | EFO_0008292 | |
| Disease | Atrial Fibrillation | 2.43e-03 | 160 | 103 | 4 | C0004238 | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.66e-03 | 22 | 103 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 2.66e-03 | 22 | 103 | 2 | C1843687 | |
| Disease | Granulomatous Slack Skin | 2.66e-03 | 22 | 103 | 2 | C0376407 | |
| Disease | Nasopharyngeal carcinoma | 2.66e-03 | 22 | 103 | 2 | C2931822 | |
| Disease | chronic widespread pain | 2.91e-03 | 23 | 103 | 2 | EFO_0010099 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.91e-03 | 23 | 103 | 2 | C0079773 | |
| Disease | partial thromboplastin time | 3.17e-03 | 24 | 103 | 2 | EFO_0004310 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VNPKKPKPSESVSGA | 186 | Q6N043 | |
| PPRTKNITAKNPAKS | 546 | Q6N043 | |
| GSKGVKQKSPPAAVA | 541 | P51826 | |
| PSSDSKLNKPLSPQK | 936 | Q8N5R6 | |
| SAKPKFSKPFNPLQN | 871 | Q5T601 | |
| PASAVGTPDKAQKAP | 591 | Q96L96 | |
| QKIKKSTPAAGQPPH | 96 | Q9H211 | |
| SSVPEAGGPPIKKQK | 121 | Q8IXM2 | |
| SEQPQFPGKSKKPSS | 81 | Q9ULD4 | |
| RKDSPPPGKVSSQKQ | 536 | A6QL64 | |
| PPGKVSSQKQPAEKA | 541 | A6QL64 | |
| TASPGSQLKAKPPKK | 151 | O43918 | |
| APPKDTKKGAQPSPF | 886 | Q68CQ1 | |
| KRVGKPSPKAASSPS | 1096 | Q7Z5J4 | |
| PKKAKPTKGNGEPAT | 1276 | Q7Z5J4 | |
| NSPGQPNSVKRKKLP | 676 | P49756 | |
| GRPSKTPSPSQPKKN | 1376 | Q9NTI5 | |
| DGGKTLPKQPSPQKS | 256 | Q6PCD5 | |
| ADSKKSQPKIQPPSP | 1121 | O14497 | |
| KDSPPPGKVSSQKQP | 571 | Q5JPF3 | |
| ASKPNSTVPKGEAKP | 676 | Q6Y2X3 | |
| KSQKATAPNKPPALS | 381 | Q86VZ4 | |
| KAKTQPTSLPKQPAP | 716 | P27816 | |
| KQPAPTTIGGLNKKP | 726 | P27816 | |
| APPQLSKSKGLPKSA | 366 | Q9HCH0 | |
| KVPTSAPSLGKPNKS | 796 | Q9HCH0 | |
| KKGSQGAIPPPDKAQ | 26 | O60565 | |
| NPKFNPPKSSKNTDF | 536 | Q09328 | |
| SIINPKNPKEAPKSF | 36 | O60333 | |
| KPAPGADKSTPLTNK | 891 | O43150 | |
| PQSKSSFPLPGRKNK | 171 | Q9NYS0 | |
| SPSKEPKPVGLNNKE | 456 | O43525 | |
| PPSTPKHKKSQKGSA | 576 | O43525 | |
| GKKAPVQAAKLPSPA | 131 | Q8IY33 | |
| GAPQLQSESKPPKKK | 191 | Q5T3I0 | |
| THPKNAPESKKGSSP | 426 | Q9UKJ3 | |
| IQSKDGNKPPPLKTS | 556 | Q8NEN9 | |
| AQVSKPTQGSAFKPP | 576 | Q8NEN9 | |
| KVSPKLAPPKAGSKN | 441 | Q8IVL0 | |
| KQQASPSCPKNIKTP | 816 | Q8IXT1 | |
| QPTPPSEAAASKKKP | 151 | Q86UP2 | |
| NRKPSPAASPATKKA | 636 | Q8N3F8 | |
| KSSQPDPDKNPASSK | 1616 | P46013 | |
| NTSSSPQPKKKPLDG | 311 | P04637 | |
| KDNPPNIPSSSSKPK | 411 | Q15070 | |
| STPQKGPSTHPKEKA | 401 | Q68DK7 | |
| SKAAPQSPSVPKKPG | 986 | O75694 | |
| SADGSQPPKKKPKTT | 441 | Q15291 | |
| PAPGHQQAQKSPKAK | 201 | O60240 | |
| PQPKPSVQKTKDASS | 471 | P49643 | |
| GKQTPQASKPPAPKT | 31 | Q8N573 | |
| KTGDPNKPVPQDTKF | 566 | Q9NZ94 | |
| KPKNLNKSKTPAAPS | 321 | P43694 | |
| SFKSKPKANGNPSPQ | 691 | O14523 | |
| SKNTQASSPPVGIPK | 681 | Q4KMG0 | |
| KGQPDAKIPPNAKLT | 201 | Q00688 | |
| KKQNSPVAPTAQPKA | 451 | Q6P1N0 | |
| GATPSPSNETPKKKK | 141 | P29966 | |
| QKPVSKPGPNKVTSS | 781 | Q86V48 | |
| PAKNPSSLFSKEAPK | 61 | Q9GZR7 | |
| GKTSPDKQKQSPQPQ | 626 | P20807 | |
| KASLAKTASGQAPKP | 856 | B7ZC32 | |
| FNPPVESSNPKIKGK | 746 | Q8WTT2 | |
| PAKTSAVSNTKPGQP | 16 | Q8NDC0 | |
| APSPANKAKKQPLFG | 811 | B1AL46 | |
| GSKSKKQDPNAPPQN | 411 | Q15542 | |
| KSSSQPSPSGPKKKT | 21 | O14598 | |
| AEQPCNPSKPKAKTS | 181 | Q9NUQ6 | |
| NPSKPKAKTSPVKSN | 186 | Q9NUQ6 | |
| PEPKTPGQSQKSKSF | 21 | B4DZS4 | |
| QVKPLGKSPQVKPAS | 496 | Q13428 | |
| AAQAKQRSPSKVKPP | 816 | Q13428 | |
| TPLANKPGKQSGHPK | 986 | P12259 | |
| QPPKSPNKSPEVKTA | 571 | Q8NE09 | |
| FKSLVNNPKTPPDGK | 1231 | Q9HCM1 | |
| PPGKNSRQVPKSTKK | 1211 | Q5QGS0 | |
| ASAPAPTSPKKPKIQ | 86 | Q8IXR5 | |
| FLKSTQKSPATAPKP | 216 | Q07960 | |
| KKGNSPNSEPPTPKT | 376 | P48634 | |
| KSQGKPKTPVSSQAP | 1101 | Q92835 | |
| VPSTKKGKSQPFINP | 581 | Q149N8 | |
| QEPGSPKAKAPQKSQ | 1181 | Q6ZUB1 | |
| SKKAPPPSGASQTIK | 116 | Q92954 | |
| ATNSKATTPKPQKPT | 1011 | Q92954 | |
| SURUKNQAKKUEUPS | 366 | P49908 | |
| SVLFSKKNPKTAGPP | 891 | P55201 | |
| TKTPDGNKSPAPKPS | 751 | Q05682 | |
| TRPKGQPLSSPKKNS | 196 | Q96LP6 | |
| PNISNKPKSSKDPSF | 611 | Q70EK8 | |
| KAGRPSKPPSPKQNV | 286 | Q9P2M4 | |
| EPATNTLPKNPGDKK | 1001 | Q9Y4G8 | |
| PLQPKAQAGAKSRPK | 2736 | O15417 | |
| LGQPDPAPSKKKSNR | 186 | Q9H0M4 | |
| PASKAPQQPGKEAAK | 3221 | Q96T58 | |
| PQQPGKEAAKTPDAK | 3226 | Q96T58 | |
| AAKPAAAGAPPAKTK | 21 | P14649 | |
| HATGKKSPAKSPNPS | 386 | O76021 | |
| ESNIPKSSAKPIQPK | 146 | Q86VQ3 | |
| LGNIPKASVKPSQPK | 161 | Q86VQ3 | |
| LGNIPKASVKPSQPK | 266 | Q86VQ3 | |
| EPVASPAKKPKVQSG | 1431 | Q15149 | |
| PPPAKGKKNKVSTSR | 811 | A7E2V4 | |
| KASPSSTNKRKNKPP | 491 | Q9ULD9 | |
| KQPQTKTKPTQAAGP | 431 | P18887 | |
| KTKPTQAAGPSSPQK | 436 | P18887 | |
| PAQSKSLPSAKGKQS | 781 | O75362 | |
| PGKPSSKSQNKCKPS | 476 | Q6NXT6 | |
| PQAAKSPSPVQGKKS | 96 | Q96JP5 | |
| APAQPKKESSPKSQD | 1091 | Q70CQ4 | |
| KGTKKPSALQPPNTL | 191 | A0PK05 | |
| KPPAPKSTQENNTKQ | 176 | Q01085 | |
| KSPKPAESPQSATKQ | 1036 | Q5VUA4 | |
| PAQKPKTSSGTKPSV | 606 | Q14966 | |
| PKVNKKAGSPGTPAK | 196 | A6NI61 | |
| PKQVATSSSPKKAPA | 1481 | E9PAV3 | |
| PQASKGLPAKKGPTA | 1666 | E9PAV3 | |
| RKGPQTKKSSATSPP | 1701 | E9PAV3 | |
| PAVQKKKPGDASSLP | 1386 | Q13459 | |
| PQKAAPQGKSKSDPL | 911 | P52179 | |
| PSQGLAKKNTKSPQP | 856 | Q86TC9 | |
| SEKGQPQNSKKQSPP | 41 | P56181 |